SABBY MANAGEMENT, LLC - PHARMACYTE BIOTECH INC ownership

Back to all holdings Add to watchlist

PHARMACYTE BIOTECH INC's ticker is and the CUSIP is 71715X953. A total of 2 filers reported holding PHARMACYTE BIOTECH INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q3 2022$414,000
+7.3%
1,7230.0%0.52%
+98.5%
Q2 2022$386,000
+144.3%
1,723
+150.8%
0.26%
+995.8%
Q1 2022$158,000
-4.8%
687
+3.3%
0.02%0.0%
Q4 2021$166,000
+18.6%
665
+50.8%
0.02%
+26.3%
Q3 2021$140,000–441–0.02%–
 Download
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 441$140,0000.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PHARMACYTE BIOTECH INC shareholders